PTPRC and Parkinson disease: The results of this study demonstrate that TSPO expression was mainly upregulated in CD45+CD11b+ microglia in MPTP-induced mice compared with control mice, and the immunofluorescence results also showed that the number of TSPO+Iba1+ cells was significantly increased, indicating that TSPO could be used as a new target for treating PD.